S'abonner

Vascular health years after a hypertensive disorder of pregnancy: The EPOCH study - 04/05/24

Doi : 10.1016/j.ahj.2024.03.004 
Hayley E. Miller, MD a, Seda Tierney, MD b, Marcia L. Stefanick, PhD c, a, Jonathan A. Mayo, MPH a, b, Oshra Sedan, PhD d, Lisa G. Rosas, MPH, PhD e, c, Mads Melbye, MD, DrMed f, Heather A. Boyd, PhD g, David K. Stevenson, MD b, Gary M. Shaw, DrPH b, Virginia D. Winn, MD, PhD a, , Mark A. Hlatky, MD d, c, ,
a Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 
b Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 
c Department of Medicine, Stanford University School of Medicine, Stanford, CA 
d Department of Health Policy, Stanford University School of Medicine, Stanford, CA 
e Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA 
f Danish Cancer Institute, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark 
g Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark 

Reprint requests: Mark A Hlatky MD, Stanford University School of Medicine, Encina Commons, Room 200, 615 Crothers Way, Stanford, CA 94305-6006Stanford University School of MedicineEncina Commons, Room 200, 615 Crothers WayStanfordCA94305-6006

ABSTRACT

Background

Preeclampsia is associated with a two-fold increase in a woman's lifetime risk of developing atherosclerotic cardiovascular disease (ASCVD), but the reasons for this association are uncertain. The objective of this study was to examine the associations between vascular health and a hypertensive disorder of pregnancy among women ≥ 2 years postpartum.

Methods

Pre-menopausal women with a history of either a hypertensive disorder of pregnancy (cases: preeclampsia or gestational hypertension) or a normotensive pregnancy (controls) were enrolled. Participants were assessed for standard ASCVD risk factors and underwent vascular testing, including measurements of blood pressure, endothelial function, and carotid artery ultrasound. The primary outcomes were blood pressure, ASCVD risk, reactive hyperemia index measured by EndoPAT and carotid intima-medial thickness. The secondary outcomes were augmentation index normalized to 75 beats per minute and pulse wave amplitude measured by EndoPAT, and carotid elastic modulus and carotid beta-stiffness measured by carotid ultrasound.

Results

Participants had a mean age of 40.7 years and were 5.7 years since their last pregnancy. In bivariate analyses, cases (N = 68) were more likely than controls (N = 71) to have hypertension (18% vs 4%, P = .034), higher calculated ASCVD risk (0.6 vs 0.4, P = .02), higher blood pressures (systolic: 118.5 vs 111.6 mm Hg, P = .0004; diastolic: 75.2 vs 69.8 mm Hg, P = .0004), and higher augmentation index values (7.7 vs 2.3, P = .03). They did not, however, differ significantly in carotid intima-media thickness (0.5 vs 0.5, P = .29) or reactive hyperemia index (2.1 vs 2.1, P = .93), nor in pulse wave amplitude (416 vs 326, P = .11), carotid elastic modulus (445 vs 426, P = .36), or carotid beta stiffness (2.8 vs 2.8, P = .86).

Conclusion

Women with a prior hypertensive disorder of pregnancy had higher ASCVD risk and blood pressures several years postpartum, but did not have more endothelial dysfunction or subclinical atherosclerosis.

Le texte complet de cet article est disponible en PDF.

Non-standard abbreviations and acronyms : AI@75, ASCVD, CIMT, EPOCH, HDP, REDCap, RHI


Plan


© 2024  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 272

P. 96-105 - juin 2024 Retour au numéro
Article précédent Article précédent
  • Hemodynamic, ventilatory and gas exchange responses to exercise using a cycle ergometer and the incremental shuttle walk test in pregnant women
  • Alicia Therese Dennis, Emily Traer, Hilmy Ismail, Bernhard Riedel
| Article suivant Article suivant
  • Rationale and design of NUDGE-FLU-CHRONIC and NUDGE-FLU-2: Two nationwide randomized trials of electronic nudges to increase influenza vaccination among patients with chronic diseases and older adults during the 2023/2024 influenza season
  • Niklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S. Bhatt, Daniel Modin, Safia Chatur, Brian L. Claggett, Kira Hyldekær Janstrup, Carsten Schade Larsen, Lykke Larsen, Lothar Wiese, Michael Dalager-Pedersen, Lars Køber, Scott D. Solomon, Pradeesh Sivapalan, Jens Ulrik Stæhr Jensen, Cyril Jean-Marie Martel, Tyra Grove Krause, Tor Biering-Sørensen

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.